메뉴 건너뛰기




Volumn 115, Issue 12, 2015, Pages 1696-1699

Relation Between Dabigatran Concentration, as Assessed Using the Direct Thrombin Inhibitor Assay, and Activated Clotting Time/Activated Partial Thromboplastin Time in Patients With Atrial Fibrillation

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; VERAPAMIL; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE;

EID: 84930177263     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.03.013     Document Type: Article
Times cited : (13)

References (13)
  • 1
    • 84896055390 scopus 로고    scopus 로고
    • Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation
    • S. Sardar, R. Nairooz, S. Chatterjee, J. Wetterslev, J. Ghosh, and W.S. Aronow Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation Am J Cardiol 113 2014 1173 1177
    • (2014) Am J Cardiol , vol.113 , pp. 1173-1177
    • Sardar, S.1    Nairooz, R.2    Chatterjee, S.3    Wetterslev, J.4    Ghosh, J.5    Aronow, W.S.6
  • 2
    • 84885002072 scopus 로고    scopus 로고
    • Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature
    • S.H. Hohnloser, and A.J. Camm Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature Europace 15 2013 1407 1411
    • (2013) Europace , vol.15 , pp. 1407-1411
    • Hohnloser, S.H.1    Camm, A.J.2
  • 3
    • 84897449184 scopus 로고    scopus 로고
    • Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter
    • A. Yadlapati, C. Groh, and R. Passman Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter Am J Cardiol 113 2014 1362 1363
    • (2014) Am J Cardiol , vol.113 , pp. 1362-1363
    • Yadlapati, A.1    Groh, C.2    Passman, R.3
  • 5
    • 77953168824 scopus 로고    scopus 로고
    • Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity
    • J. van Ryn, J. Stangier, S. Haertter, K.H. Liesenfeld, W. Wienen, M. Feuring, and A. Clemens Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127
    • (2010) Thromb Haemost , vol.103 , pp. 1116-1127
    • Van Ryn, J.1    Stangier, J.2    Haertter, S.3    Liesenfeld, K.H.4    Wienen, W.5    Feuring, M.6    Clemens, A.7
  • 6
    • 84856593171 scopus 로고    scopus 로고
    • Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran
    • J. Stangier, and M. Feuring Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran Blood Coagul Fibrinolysis 23 2012 138 143
    • (2012) Blood Coagul Fibrinolysis , vol.23 , pp. 138-143
    • Stangier, J.1    Feuring, M.2
  • 7
    • 41949116970 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate
    • J. Stangier Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate Clin Pharmacokinet 47 2008 285 295
    • (2008) Clin Pharmacokinet , vol.47 , pp. 285-295
    • Stangier, J.1
  • 8
    • 84955632791 scopus 로고    scopus 로고
    • Accessed on December 22, 2014
    • Boehringer Ingelheim. Pradaxa product monograph. Available at: http://www.boehringer-ingelheim.ca/en/content/dam/internet/opu/ca-EN/documents/humanhealth/product-monograph/PradaxaPMEN.pdf. Accessed on December 22, 2014.
    • Pradaxa product monograph
    • Boehringer Ingelheim1
  • 9
    • 79953656178 scopus 로고    scopus 로고
    • Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation - sub-analysis in Japanese population in RE-LY trial
    • M. Hori, S.J. Connolly, M.D. Ezekowitz, P.A. Reilly, S. Yusuf, and L. Wallentin Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation - sub-analysis in Japanese population in RE-LY trial Circ J 75 2011 800 805
    • (2011) Circ J , vol.75 , pp. 800-805
    • Hori, M.1    Connolly, S.J.2    Ezekowitz, M.D.3    Reilly, P.A.4    Yusuf, S.5    Wallentin, L.6
  • 10
    • 33646470969 scopus 로고    scopus 로고
    • An overview of the structure and function of thrombin
    • E.W. Davie, and J.D. Kulman An overview of the structure and function of thrombin Semin Thromb Hemost 32 suppl 1 2006 3 15
    • (2006) Semin Thromb Hemost , vol.32 , pp. 3-15
    • Davie, E.W.1    Kulman, J.D.2
  • 11
    • 84871744380 scopus 로고    scopus 로고
    • The effect of dabigatran on select specialty coagulation assays
    • D.M. Adcock, R. Gosselin, S. Kitchen, and D.M. Dwyre The effect of dabigatran on select specialty coagulation assays Am J Clin Pathol 139 2013 102 109
    • (2013) Am J Clin Pathol , vol.139 , pp. 102-109
    • Adcock, D.M.1    Gosselin, R.2    Kitchen, S.3    Dwyre, D.M.4
  • 12
    • 84875071896 scopus 로고    scopus 로고
    • Oral bioavailability of dabigatran etexilate (Pradaxa(®)) after co-medication with verapamil in healthy subjects
    • S. Hartter, R. Sennewald, G. Nehmiz, and P. Reilly Oral bioavailability of dabigatran etexilate (Pradaxa(®)) after co-medication with verapamil in healthy subjects Br J Clin Pharmacol 75 2013 1053 1062
    • (2013) Br J Clin Pharmacol , vol.75 , pp. 1053-1062
    • Hartter, S.1    Sennewald, R.2    Nehmiz, G.3    Reilly, P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.